Immucell (ICCC) Inventory (2010 - 2026)
Immucell's (ICCC) quarterly Inventory came in at $9.3 million in Q4 2025, up 30.29% YoY from $7.1 million in Q4 2024, and down 5.45% on a QoQ basis from $9.8 million in Q3 2025.
Immucell (ICCC) Inventory (2010 - 2026) Analysis & Trends
Immucell (ICCC) has 16 years of Inventory data on file, last reported at $9.3 million in Q4 2025.
- Quarterly Inventory rose 30.29% year-over-year to $9.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.3 million (up 30.29% YoY) and the FY2025 annual result came in at $9.3 million, up 30.29% from the prior year.
- Inventory eased to $9.3 million in Q4 2025, from $9.8 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $9.8 million in Q3 2025 to a low of $2.1 million in Q1 2021.
- A 5-year average of $6.1 million and a median of $7.1 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory surged 99.39% — and 2024, when it dropped 8.95%.
- Tracing ICCC's Inventory over 5 years: stood at $3.1 million in 2021, then soared by 95.42% to $6.0 million in 2022, then advanced by 29.37% to $7.8 million in 2023, then retreated by 8.95% to $7.1 million in 2024, then soared by 30.29% to $9.3 million in 2025.
- The last three Inventory figures came in at $9.3 million (Q4 2025), $9.8 million (Q3 2025), and $8.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.88 Bn | 132.03 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.62 Bn | 78.62 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.10 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 61.39 Bn | 56.25 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.37 Bn | 28.06 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.76 Bn | 10.37 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Immucell | 95.12 Mn | 86.26 Mn | 2.44 Mn | 9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.08 Mn |
| Dec 31, 2025 | 9.27 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 8.29 Mn |
| Mar 31, 2025 | 7.36 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Dec 31, 2023 | 7.81 Mn |
| Sep 30, 2023 | 7.39 Mn |
| Jun 30, 2023 | 7.54 Mn |
| Mar 31, 2023 | 6.33 Mn |
| Dec 31, 2022 | 6.04 Mn |
| Sep 30, 2022 | 5.32 Mn |
| Jun 30, 2022 | 4.60 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 3.09 Mn |
| Sep 30, 2021 | 2.67 Mn |
| Jun 30, 2021 | 2.42 Mn |